These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Newer Understanding of Specific Anatomic Targets in the Aging Face as Applied to Injectables: Facial Muscles--Identifying Optimal Targets for Neuromodulators. Sykes JM; Trevidic P; Suárez GA; Criollo-Lamilla G Plast Reconstr Surg; 2015 Nov; 136(5 Suppl):56S-61S. PubMed ID: 26441113 [TBL] [Abstract][Full Text] [Related]
4. Cosmetic indications for botulinum A toxin. Foster JA; Wulc AE; Holck DE Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin below the eyes. Carruthers J; Carruthers A Int Ophthalmol Clin; 2005; 45(3):133-41. PubMed ID: 15970772 [No Abstract] [Full Text] [Related]
7. Injectable treatments for the aging face. Wise JB; Greco T Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805 [TBL] [Abstract][Full Text] [Related]
8. Injectable agents for facial rejuvenation: botulinum toxin and dermal filling agents. Mandeville JT; Rubin PA Int Ophthalmol Clin; 2004; 44(1):189-212. PubMed ID: 14704531 [No Abstract] [Full Text] [Related]
9. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead? Kim YJ; Lim OK; Choi WJ Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751 [TBL] [Abstract][Full Text] [Related]
10. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Fagien S Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Lowe NJ Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741 [TBL] [Abstract][Full Text] [Related]
13. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Carruthers A; Carruthers J Dermatol Surg; 1998 Nov; 24(11):1189-94. PubMed ID: 9834738 [TBL] [Abstract][Full Text] [Related]
14. Advancements and Refinement in Facial Neuromodulators. Kordestani R; Small KH; Rohrich RJ Plast Reconstr Surg; 2016 Oct; 138(4):803-806. PubMed ID: 27673516 [TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxin type B--a rapid wrinkle reducer. Jacob CI Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232 [TBL] [Abstract][Full Text] [Related]
16. The adjunctive usage of botulinum toxin. Carruthers J; Carruthers A Dermatol Surg; 1998 Nov; 24(11):1244-7. PubMed ID: 9834746 [TBL] [Abstract][Full Text] [Related]
17. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks? Kapoor R; Shome D; Jain V; Dikshit R Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041 [TBL] [Abstract][Full Text] [Related]
18. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Edelstein C; Shorr N; Jacobs J; Balch K; Goldberg R Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740 [TBL] [Abstract][Full Text] [Related]
19. Different Dilutions of Mesobotox in Facial Rejuvenation: Which is Better? Salem SA; Seoudy WM; Abd El-Rahman NS; Afify AA Aesthetic Plast Surg; 2024 Sep; 48(18):3669-3680. PubMed ID: 38714537 [TBL] [Abstract][Full Text] [Related]
20. The face recurve concept: medical and surgical applications. Le Louarn C; Buthiau D; Buis J Aesthetic Plast Surg; 2007; 31(3):219-31; discussion 232. PubMed ID: 17484058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]